por filla | May 9, 2022 | Claudio Jofre C.
natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases. Peptides. 2011 May;32(5):852-8. doi:...
por filla | May 9, 2022 | Claudio Jofre C.
Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: An approach for their use in neural regeneration therapies. PLoS One. 2019 Mar 11;14(3):e0213032. doi: 10.1371/journal.pone.0213032. eCollection 2019....
por filla | May 9, 2022 | Claudio Jofre C.
Stem Cell Therapy in Refractory Perineal Crohn’s Disease: Long-term Follow-up. Colorectal Dis. 2018 Jan 6. doi: 10.1111/codi.14002. AbstractAim: To describe the long-term outcomes of adipose-mesenchymal stem cells, platelet-rich plasma, and endorectal...
por filla | May 9, 2022 | Claudio Jofre C.
Cell therapy for cartilage defects of the hip. Muscles Ligaments Tendons J. 2016 Dec 21;6(3):361-366. doi: 10.11138/mltj/2016.6.3.361. eCollection Jul-Sep 2016. AbstractBackground: Chondral injuries are commonly related to poor clinical outcome, but recent data showed...
por filla | May 9, 2022 | Claudio Jofre C.
Mesenchymal stem cell therapy in the treatment of hip osteoarthritis. J Hip Preserv Surg. 2017 Mar 19;4(2):159-163. doi: 10.1093/jhps/hnx011. eCollection 2017 Jul. AbstractThis study was performed to investigate the safety and efficacy of the intra-articular infusion...
por filla | May 9, 2022 | Claudio Jofre C.
Treatment of osteonecrosis of the femoral head by core decompression and implantation of fully functional ex vivo-expanded bone marrow-derived mesenchymal stem cells: a proof-of-concept study. Stem Cells Cloning. 2019 Mar 1;12:11-16. doi: 10.2147/SCCAA.S181883....
